Vanda Pharmaceuticals Inc. · NASDAQ:VNDA
BlackRock Portfolio Management LLC reported a 7.70% stake in Vanda Pharmaceuticals Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed Apr 15, 2025
BlackRock Portfolio Management LLC reported a 7.70% stake in Vanda Pharmaceuticals Inc., 4,479,086 shares, as a passive investor on Mar 31, 2025. Filed Apr 15, 2025 (Schedule 13G).
- Stake
- 7.70%
- Shares
- 4,479,086
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 7.70% | 4,479,086 |
Source
Related
- Vanda Pharmaceuticals Inc.
- BlackRock Portfolio Management LLC
- Vanda Pharmaceuticals Inc. shareholders
- Schedule 13G/A · BlackRock Portfolio Management LLC · Apr 29, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jan 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 9, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Form 4 · McGuire Daniel Patrick · Jun 8, 2026
- Form 4 · Chrousos Phaedra · Jun 8, 2026